Genomic variants within the long non-coding RNA H19 confer risk of breast cancer in Iranian population.


Journal

Gene
ISSN: 1879-0038
Titre abrégé: Gene
Pays: Netherlands
ID NLM: 7706761

Informations de publication

Date de publication:
15 Jun 2019
Historique:
received: 18 02 2019
revised: 08 03 2019
accepted: 19 03 2019
pubmed: 27 3 2019
medline: 1 5 2019
entrez: 27 3 2019
Statut: ppublish

Résumé

The long non-coding RNA (lncRNA) H19 is an imprinted lncRNA with acknowledged roles in carcinogenesis. In the current study, we genotyped two single nucleotide polymorphisms (SNPs) within H19 in 111 breast cancer patients and 130 age-matched healthy subjects using tetra primer-ARMS-PCR technique. The T allele of rs2839698 conferred breast cancer risk in the assessed population (OR (95% CI) = 2.52 (1.75-3.64), adjusted P value = 1.3E-6), while and the T allele of rs217727 had a protective effect (OR (95% CI) = 0.42 (0.27-0.66), adjusted P value = 2.8E-4). Both SNPs were associated with breast cancer risk in recessive, dominant and co-dominant models. The T C haplotype (rs2839698 and rs217727) significantly increased risk of breast cancer (OR (95% CI) = 2.4 (1.65-3.45), adjusted P value = 1.2E-5), while the C T haplotype had a protective role (OR (95% CI) = 0.31 (0.18-0.52), adjusted P value = 2.03E-5). The present study highlights the role of H19 SNPs in conferring risk of breast cancer in Iranian population. Future studies with larger sample sizes are required to verify these data.

Identifiants

pubmed: 30910558
pii: S0378-1119(19)30293-8
doi: 10.1016/j.gene.2019.03.036
pii:
doi:

Substances chimiques

H19 long non-coding RNA 0
RNA, Long Noncoding 0
RNA, Neoplasm 0

Types de publication

Clinical Trial Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

121-124

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Mohammad Reza Safari (MR)

Department of Medical Laboratory Sciences, School of Para Medicine, Hamadan University of Medical Sciences, Hamadan, Iran.

Fatemeh Mohammad Rezaei (F)

Department of Medical Genetic, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.

Arash Dehghan (A)

Department of Pathology, Hamadan University of Medical Sciences, Hamadan, Iran.

Rezvan Noroozi (R)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Mohammad Taheri (M)

Urogenital Stem Cell Research Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: Mohammad.taheri@sbmu.ac.ir.

Soudeh Ghafouri-Fard (S)

Department of Medical Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Iran. Electronic address: s.ghafourifard@sbmu.ac.ir.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH